BioAtlantis Ltd., Clash Industrial Estate, Tralee, Co. Kerry, Ireland. :: Tel: +353 66 711 8477 :: Fax:+353 66 7119802 :: Click here to email us
about bioatlantis

The Company

image

BioAtlantis Ltd. was founded in 2004 and is located in Tralee, County Kerry, Ireland. The company was founded with the objective of identifying solutions to problems caused by stresses which impact upon biological processes in plants, animals and humans.

Since then, BioAtlantis has put in place the foundations to be a successful high-growth company. These foundations include a large body of scientific data and the filing of a number of patents. A fully automated extraction facility has been commissioned together with approval licenses. BioAtlantis is the first company in the British Isles to be granted a mechanical harvesting license for specific species of seaweed, which are sources of key bio actives.

A range of products including Super Fifty® 0-0-8, Alga 95®, Ecolicitor® and Nematec® have been developed for the plant strengthener sector to alleviate some of the problems caused by biotic and abiotic stresses. These products have been intensively trialed in research institutes which include the Applied Food and Bioscience Institute, Belfast, Northern Ireland (AFBI) and University College Cork, Ireland (UCC). The effectiveness of these products has also been verified through an intensive field trial process taking place in several countries. These products are registered for sale in many countries worldwide including Brazil, South Korea, Vietnam, Turkey and USA.

GutCare™ is our proprietary technology platform on gut health, performance and immunity in the monogastric animal. It has been developed over the last eight years in conjunction with the School of Science and Veterinary Medicine in University College Dublin, Ireland. State-of-the-art techniques have been used to develop this technology both in laboratory and on field-trial settings with effectiveness being determined over a broad range of key parameters including performance, immunity and maternal transfer and pathology. GutCare™ is subject to a number of patents and eighteen peer-reviewed papers have been published which cover these different aspects. The abstracts are available on this website.

Digestica® has been developed for the human market and offers potential solutions to those suffering from gastrointestinal health problems and autoimmune issues.  Publications describing the effectiveness of this technology in human trials are soon to be published. The focus of the company now is to bring these solutions to the market in conjunction with appropriately qualified channel partners.






Latest News:

BIM Seafood Capital Investment Scheme

BioAtlantis Ltd is delighted to participate in the Capital Seafood Investment Scheme which is supported by Bord Iascaigh Mhara and the European Union as part of our mission to ensure production of high value added products from Seaweed. The scheme aims to encourage innovation, enhance scale and competitiveness in industry, and provide capital investment in new technologies. http://www.bioatlantis.com/images/uploads/poster1.jpg



bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis